(2R,3S)-2-(4-(but-2-ynyloxy)phenylsulfonamido)-N,3-dihydroxybutanamide

ID: ALA484261

PubChem CID: 15985818

Max Phase: Preclinical

Molecular Formula: C14H18N2O6S

Molecular Weight: 342.37

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC#CCOc1ccc(S(=O)(=O)N[C@@H](C(=O)NO)[C@H](C)O)cc1

Standard InChI:  InChI=1S/C14H18N2O6S/c1-3-4-9-22-11-5-7-12(8-6-11)23(20,21)16-13(10(2)17)14(18)15-19/h5-8,10,13,16-17,19H,9H2,1-2H3,(H,15,18)/t10-,13+/m0/s1

Standard InChI Key:  VMOSDDURWLNMNG-GXFFZTMASA-N

Molfile:  

     RDKit          2D

 23 23  0  0  0  0  0  0  0  0999 V2000
   -1.8348  -17.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8359  -18.6940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1211  -19.1069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4047  -18.6935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4075  -17.8630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1229  -17.4539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3105  -19.1049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0243  -18.6913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0167  -17.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0125  -17.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0083  -16.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5493  -17.4543    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2667  -17.0417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1375  -16.7395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9590  -18.1704    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2680  -16.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9831  -15.8053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5542  -15.8030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9844  -14.9803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6969  -16.2189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4120  -15.8076    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5555  -14.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8390  -16.2144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  2  0
  1 12  1  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 12 14  2  0
  4  7  1  0
 12 15  2  0
  3  4  2  0
 13 16  1  0
  7  8  1  0
 16 17  1  1
 16 18  1  0
  8  9  1  0
 17 19  2  0
  4  5  1  0
 17 20  1  0
  9 10  3  0
 20 21  1  0
  2  3  1  0
 18 22  1  0
 10 11  1  0
 18 23  1  6
M  END

Alternative Forms

1. Parent:

   

   ALA484261

   (2R,3S)-2-(4-(but-2-ynyloxy)phenylsulfonamido)-N,3-dihydroxybutanamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 342.37

Molecular Weight (Monoisotopic): 342.0886

AlogP: -0.38

#Rotatable Bonds: 7

Polar Surface Area: 124.96

Molecular Species: NEUTRAL

HBA: 6

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.68

CX Basic pKa: ┄

CX LogP: 0.32

CX LogD: 0.29

Aromatic Rings: 1

Heavy Atoms: 23

QED Weighted: 0.30

Np Likeness Score: -0.68

References

1. Georgiadis D, Yiotakis A..  (2008)  Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,  16  (19): [PMID:18790648] [10.1016/j.bmc.2008.08.058]

Source

Source(1):

• Scientific Literature